Literature DB >> 23384441

Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.

Amir Abbas Mokhtarieh1, Semi Kim, Yunhee Lee, Bong Hyun Chung, Myung Kyu Lee.   

Abstract

Cell penetrating peptides (CPPs) have been used to transport macromolecules into cells. Most CPPs have properties such as a strong polycationic charge, amphipathic basic, and hydrophobicity. In this study, we designed the peptides with multiple motifs composed of RGD and its analogs to induce integrin-mediated endocytosis as well as endosomal escape by forming an amphipathic helix in acidic endosomes. These peptides were proved less toxic to animal cells than those without acidic residues. Unexpectedly, peptide conjugated liposomes could penetrate into cells regardless of integrins. The replacement of all aspartic acids by glutamic acids did not prevent the peptide-mediated liposome uptake, and the higher basic and leucine contents enhanced the gene silencing activity of siRNA encapsulated in the liposomes. The peptide is considered to be a new type of CPP which can be used for drug delivery.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384441     DOI: 10.1016/j.bbrc.2013.01.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Engineering a Virus-like Particle to Display Peptide Insertions Using an Apparent Fitness Landscape.

Authors:  Stephanie A Robinson; Emily C Hartman; Bon C Ikwuagwu; Matthew B Francis; Danielle Tullman-Ercek
Journal:  Biomacromolecules       Date:  2020-09-03       Impact factor: 6.988

Review 2.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

3.  Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.

Authors:  Lee B Sims; Louis T Curtis; Hermann B Frieboes; Jill M Steinbach-Rankins
Journal:  J Nanobiotechnology       Date:  2016-04-22       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.